Stock CYTO CYTOPHAGE TECHNOLOGIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cytophage Technologies Ltd.

Equities

CYTO

CA2328211081

Pharmaceuticals

Market Closed - Toronto S.E.
Other stock markets
 20:59:30 31/05/2024 BST 		5-day change 1st Jan Change
0.49 CAD +6.52% Intraday chart for Cytophage Technologies Ltd. +2.08% -30.46%
05-27 Cytophage Technologies Ltd. Strengthens Board of Directors CI
04-30 Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 - -
Enterprise Value (EV) 1 - -
P/E ratio -5.07 x -6.45 x
Yield - -
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA - -
EV / FCF - -
FCF Yield - -
Price to Book 5.41 x 80.9 x
Nbr of stocks (in thousands) - -
Reference price 2 0.4559 0.7046
Announcement Date 30/04/24 30/04/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023
Net sales - -
EBITDA 1 -4.028 -4.74
EBIT 1 -4.248 -5.039
Operating Margin - -
Earnings before Tax (EBT) 1 -3.682 -4.635
Net income 1 -3.682 -4.635
Net margin - -
EPS 2 -0.0900 -0.1092
Free Cash Flow - -1.259
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 30/04/24 30/04/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023
Net Debt 1 - 1.76
Net Cash position 1 2.14 -
Leverage (Debt/EBITDA) - -0.3703 x
Free Cash Flow - -1.26
ROE (net income / shareholders' equity) - -242%
ROA (Net income/ Total Assets) - -69%
Assets 1 - 6.721
Book Value Per Share 2 0.0800 0.0100
Cash Flow per Share 2 0.0500 0
Capex 1 0.38 0.16
Capex / Sales - -
Announcement Date 30/04/24 30/04/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
CYTOPHAGE TECHNOLOGIES LTD. Stock Cytophage Technologies Ltd.
-30.46% 15.37M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
PFIZER, INC. Stock Pfizer, Inc.
-0.45% 162B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. CYTO Stock
  4. Financials Cytophage Technologies Ltd.